コーパス検索結果(共起頻度の集計）
検索語: become
ヒット件数: 1000
| 一般的な頻出語を「文章内」のリストから除外しています |
| 2語前 |
1語前 |
|
1語後 |
2語後 |
|
文章内 |
| the |
28 |
has |
126 |
|
a |
122 |
to |
55 |
|
cells |
89 |
| it |
26 |
to |
68 |
|
more |
101 |
in |
49 |
|
increasingly |
76 |
| and |
20 |
have |
65 |
|
increasingly |
59 |
and |
46 |
|
cell |
67 |
| of |
15 |
is |
38 |
|
an |
47 |
important |
35 |
|
important |
60 |
| that |
13 |
are |
30 |
|
the |
40 |
of |
22 |
|
however |
56 |
| which |
12 |
may |
29 |
|
available |
24 |
for |
21 |
|
high |
54 |
| has |
12 |
and |
24 |
|
activated |
15 |
with |
15 |
|
disease |
53 |
| is |
9 |
can |
23 |
|
possible |
13 |
more |
15 |
|
during |
50 |
| but |
9 |
it |
18 |
|
less |
12 |
that |
14 |
|
patients |
50 |
| have |
8 |
that |
17 |
|
one |
12 |
as |
12 |
|
data |
46 |
| this |
8 |
cells |
15 |
|
resistant |
10 |
by |
11 |
|
treatment |
45 |
| cells |
7 |
recently |
13 |
|
apparent |
9 |
at |
10 |
|
time |
41 |
| cell |
6 |
they |
12 |
|
evident |
9 |
when |
10 |
|
into |
37 |
| expected |
6 |
but |
11 |
|
highly |
9 |
common |
9 |
|
species |
34 |
| these |
6 |
then |
10 |
|
important |
8 |
standard |
9 |
|
although |
33 |
| as |
5 |
will |
10 |
|
infected |
8 |
frequent |
8 |
|
over |
32 |
| likely |
5 |
not |
9 |
|
clear |
8 |
or |
8 |
|
analysis |
32 |
| potential |
5 |
could |
8 |
|
active |
6 |
during |
7 |
|
many |
32 |
| imaging |
5 |
patients |
7 |
|
susceptible |
6 |
tools |
7 |
|
results |
32 |
| when |
4 |
which |
7 |
|
stronger |
6 |
after |
7 |
|
available |
32 |
| or |
4 |
who |
6 |
|
fully |
5 |
powerful |
7 |
|
one |
31 |
| t |
4 |
rapidly |
6 |
|
essential |
5 |
from |
6 |
|
n |
31 |
| pathways |
4 |
quickly |
6 |
|
pregnant |
4 |
active |
6 |
|
because |
31 |
| proteins |
4 |
of |
5 |
|
larger |
4 |
major |
6 |
|
due |
30 |
| more |
4 |
gradually |
5 |
|
associated |
4 |
into |
6 |
|
years |
29 |
| do |
4 |
might |
5 |
|
crucial |
4 |
widely |
6 |
|
new |
29 |
| patients |
4 |
only |
5 |
|
clinically |
4 |
complex |
6 |
|
human |
27 |
| c |
3 |
would |
4 |
|
rapidly |
4 |
popular |
6 |
|
c |
27 |
| other |
3 |
or |
4 |
|
clearer |
4 |
focus |
5 |
|
response |
27 |
| intervention |
3 |
neurons |
4 |
|
uncoupled |
3 |
valuable |
5 |
|
health |
27 |
| immune |
3 |
thus |
4 |
|
critical |
3 |
relevant |
5 |
|
common |
26 |
| they |
3 |
species |
3 |
|
independent |
3 |
increasingly |
5 |
|
associated |
26 |
| transition |
3 |
responses |
3 |
|
pathogenic |
3 |
susceptible |
5 |
|
research |
26 |
| techniques |
3 |
eventually |
3 |
|
relevant |
3 |
prominent |
5 |
|
both |
26 |
| discovery |
3 |
pathways |
3 |
|
prominent |
3 |
apparent |
5 |
|
based |
26 |
| water |
3 |
macrophages |
3 |
|
functionally |
3 |
prevalent |
5 |
|
only |
26 |
| tumors |
3 |
also |
3 |
|
chronic |
3 |
targets |
4 |
|
active |
26 |
| before |
3 |
this |
3 |
|
toxic |
3 |
key |
4 |
|
increased |
25 |
| with |
3 |
data |
3 |
|
incorporated |
3 |
most |
4 |
|
protein |
25 |
| analysis |
3 |
1 |
2 |
|
prevalent |
3 |
leading |
4 |
|
less |
25 |
| systems |
3 |
concentrations |
2 |
|
powerful |
3 |
abundant |
4 |
|
under |
25 |
| a |
3 |
should |
2 |
|
very |
3 |
than |
4 |
|
expression |
25 |
| species |
3 |
materials |
2 |
|
visible |
3 |
the |
4 |
|
well |
25 |
| two |
3 |
effect |
2 |
|
dominant |
3 |
global |
4 |
|
cancer |
25 |
| will |
3 |
modules |
2 |
|
enriched |
3 |
upon |
4 |
|
potential |
25 |
| function |
3 |
from |
2 |
|
known |
3 |
new |
4 |
|
methods |
24 |
| virus |
3 |
process |
2 |
|
progressively |
3 |
dominant |
4 |
|
risk |
24 |
| data |
3 |
fungi |
2 |
|
restricted |
3 |
between |
3 |
|
increasing |
24 |
| response |
3 |
disease |
2 |
|
dependent |
3 |
under |
3 |
|
studies |
23 |
| if |
3 |
proteins |
2 |
|
ever |
3 |
severe |
3 |
|
number |
23 |
| where |
3 |
elegans |
2 |
|
attractive |
2 |
is |
3 |
|
other |
23 |
| gwas |
2 |
representations |
2 |
|
extinct |
2 |
widespread |
3 |
|
use |
23 |
| methods |
2 |
fast |
2 |
|
accessible |
2 |
large |
3 |
|
water |
23 |
| infection |
2 |
noise |
2 |
|
latent |
2 |
part |
3 |
|
show |
23 |
| patterns |
2 |
had |
2 |
|
invasive |
2 |
although |
3 |
|
function |
23 |
| health |
2 |
interactions |
2 |
|
proficient |
2 |
primary |
3 |
|
early |
23 |
| zikv |
2 |
subsequently |
2 |
|
greater |
2 |
produce |
3 |
|
care |
23 |
| antibodies |
2 |
community |
2 |
|
so |
2 |
attractive |
3 |
|
imaging |
23 |
| alleles |
2 |
generally |
2 |
|
concentrated |
2 |
difficult |
3 |
|
tool |
23 |
| cancer |
2 |
since |
2 |
|
strongly |
2 |
well |
3 |
|
highly |
23 |
| sex |
2 |
methods |
2 |
|
fixed |
2 |
first |
3 |
|
low |
23 |
| after |
2 |
growth |
2 |
|
major |
2 |
if |
3 |
|
recently |
22 |
| skills |
2 |
increasingly |
2 |
|
sufficiently |
2 |
viable |
3 |
|
recent |
22 |
| however |
2 |
pressure |
2 |
|
ineligible |
2 |
however |
3 |
|
infection |
22 |
| many |
2 |
participants |
2 |
|
isolated |
2 |
effective |
3 |
|
mice |
22 |
| change |
2 |
population |
2 |
|
sensitive |
2 |
cells |
3 |
|
all |
22 |
| type |
2 |
membrane |
2 |
|
responsive |
2 |
free |
3 |
|
s |
22 |
| procedures |
2 |
expression |
2 |
|
functional |
2 |
on |
3 |
|
surface |
21 |
| individuals |
2 |
diapedesis |
1 |
|
much |
2 |
but |
3 |
|
standard |
21 |
| their |
2 |
site |
1 |
|
widely |
2 |
topic |
2 |
|
thus |
21 |
| hypotheses |
2 |
peptidase |
1 |
|
popular |
2 |
competitive |
2 |
|
two |
21 |
| diagnosis |
2 |
vcms |
1 |
|
significant |
2 |
attached |
2 |
|
drug |
21 |
| matter |
2 |
record |
1 |
|
separated |
2 |
activated |
2 |
|
virus |
21 |
| albicans |
2 |
fission |
1 |
|
integrated |
2 |
imperative |
2 |
|
t |
20 |
| cortical |
2 |
mut |
1 |
|
pivotal |
2 |
pronounced |
2 |
|
state |
20 |
| region |
2 |
years |
1 |
|
undetectable |
2 |
indispensable |
2 |
|
energy |
20 |
| strain |
2 |
remainder |
1 |
|
widespread |
2 |
favorable |
2 |
|
if |
20 |
| responses |
2 |
scs |
1 |
|
part |
2 |
associated |
2 |
|
responses |
20 |
| limitation |
2 |
samples |
1 |
|
exposed |
2 |
positive |
2 |
|
first |
20 |
| signaling |
2 |
though |
1 |
|
linked |
2 |
very |
2 |
|
activated |
20 |
| catalysis |
2 |
axons |
1 |
|
even |
2 |
novel |
2 |
|
before |
20 |
| can |
2 |
turnover |
1 |
|
rate |
2 |
components |
2 |
|
specific |
20 |
| rate |
2 |
electrodes |
1 |
|
refractory |
2 |
commonly |
2 |
|
study |
19 |
| diseases |
2 |
initially |
1 |
|
of |
2 |
mainstay |
2 |
|
using |
19 |
| committed |
2 |
pvm |
1 |
|
seizure |
2 |
evident |
2 |
|
resistant |
19 |
| h |
2 |
ceria |
1 |
|
dominated |
2 |
differentiated |
2 |
|
through |
19 |
| in |
2 |
values |
1 |
|
entrapped |
2 |
through |
2 |
|
models |
19 |
| are |
2 |
cortex |
1 |
|
therapeutic |
2 |
clinical |
2 |
|
proteins |
19 |
| hippocampal |
2 |
constraint |
1 |
|
dysregulated |
2 |
dynamic |
2 |
|
infected |
19 |
| drugs |
2 |
epidemic |
1 |
|
oxidized |
2 |
topical |
2 |
|
systems |
19 |
| spectrometry |
2 |
workers |
1 |
|
tolerant |
2 |
stable |
2 |
|
temperature |
19 |
| nanomaterials |
2 |
reservoir |
1 |
|
advantageous |
2 |
carbon |
2 |
|
10 |
18 |
| who |
2 |
network |
1 |
|
virulent |
2 |
toward |
2 |
|
including |
18 |
| surface |
2 |
paradoxically |
1 |
|
key |
2 |
because |
2 |
|
immune |
18 |
| dependent |
2 |
enzymes |
1 |
|
faster |
2 |
gold |
2 |
|
then |
18 |
| field |
2 |
light |
1 |
|
persistently |
2 |
center |
2 |
|
conditions |
18 |
| synthesis |
2 |
currents |
1 |
|
common |
2 |
potent |
2 |
|
population |
18 |
| genomic |
2 |
people |
1 |
|
established |
2 |
only |
2 |
|
so |
18 |
| antibiotics |
2 |
institutions |
1 |
|
equivalent |
1 |
aggressive |
2 |
|
genetic |
18 |
| study |
2 |
state |
1 |
|
primary |
1 |
among |
2 |
|
non |
18 |
| events |
2 |
hes |
1 |
|
embraced |
1 |
central |
2 |
|
possible |
18 |
| meiosis |
2 |
ratio |
1 |
|
covalently |
1 |
limiting |
2 |
|
interactions |
18 |
| crystal |
2 |
monkeys |
1 |
|
insensitive |
1 |
it |
2 |
|
tissue |
18 |
| disease |
2 |
additive |
1 |
|
spontaneous |
1 |
critical |
2 |
|
levels |
18 |
| therefore |
2 |
adulterants |
1 |
|
spontaneously |
1 |
following |
2 |
|
control |
17 |
| management |
2 |
alleles |
1 |
|
noncrossovers |
1 |
public |
2 |
|
upon |
17 |
| did |
2 |
however |
1 |
|
myelinating |
1 |
worldwide |
2 |
|
genome |
17 |
| b |
2 |
92 |
1 |
|
selective |
1 |
involved |
2 |
|
complex |
17 |
| sequencing |
2 |
mutations |
1 |
|
decorated |
1 |
significant |
2 |
|
rapidly |
17 |
| memory |
2 |
genome |
1 |
|
profoundly |
1 |
accepted |
2 |
|
suggest |
17 |
| testing |
2 |
dynamics |
1 |
|
central |
1 |
reality |
2 |
|
clear |
17 |
| interactions |
2 |
datasets |
1 |
|
quite |
1 |
selective |
2 |
|
development |
17 |
| mapping |
2 |
pathologies |
1 |
|
valuable |
1 |
similar |
2 |
|
relevant |
17 |
| once |
2 |
alternans |
1 |
|
aberrantly |
1 |
predominant |
2 |
|
climate |
17 |
| infections |
2 |
identity |
1 |
|
gamergates |
1 |
infected |
2 |
|
higher |
17 |
| biological |
2 |
linkers |
1 |
|
aseismic |
1 |
enough |
2 |
|
sequencing |
16 |
| assays |
2 |
cambium |
1 |
|
relatively |
1 |
serious |
2 |
|
therapy |
16 |
| surgery |
2 |
group |
1 |
|
pigmented |
1 |
alternative |
2 |
|
multiple |
16 |
| structures |
2 |
increases |
1 |
|
unstable |
1 |
strategy |
1 |
|
type |
16 |
| treatment |
2 |
coefficient |
1 |
|
virally |
1 |
state |
1 |
|
functional |
16 |
| pathogens |
2 |
therapeutics |
1 |
|
ineffective |
1 |
auto |
1 |
|
host |
16 |
| method |
2 |
engraftment |
1 |
|
nonphotosynthetic |
1 |
versatile |
1 |
|
structure |
16 |
| mate |
2 |
variation |
1 |
|
male |
1 |
1 |
1 |
|
information |
16 |
| care |
2 |
uncoupling |
1 |
|
50 |
1 |
acidic |
1 |
|
up |
16 |
| networks |
2 |
fibers |
1 |
|
tcr |
1 |
they |
1 |
|
infections |
16 |
| wes |
1 |
compositions |
1 |
|
inapplicable |
1 |
irreversible |
1 |
|
become |
16 |
| methylation |
1 |
connectivity |
1 |
|
open |
1 |
including |
1 |
|
large |
15 |
| cleavage |
1 |
bound |
1 |
|
electromechanically |
1 |
paradigm |
1 |
|
membrane |
15 |
| chemistry |
1 |
oscillation |
1 |
|
discriminable |
1 |
negative |
1 |
|
process |
15 |
| prey |
1 |
evidence |
1 |
|
smaller |
1 |
familiar |
1 |
|
further |
15 |
| features |
1 |
often |
1 |
|
directly |
1 |
distinct |
1 |
|
several |
15 |
| mobilizers |
1 |
cdw |
1 |
|
localized |
1 |
avoiding |
1 |
|
apparent |
15 |
| alkylations |
1 |
normally |
1 |
|
nonreactive |
1 |
immunology |
1 |
|
brain |
15 |
| kit |
1 |
dementia |
1 |
|
standard |
1 |
ultimate |
1 |
|
molecular |
15 |
| otherwise |
1 |
acid |
1 |
|
co |
1 |
pests |
1 |
|
individuals |
15 |
| recent |
1 |
always |
1 |
|
eligible |
1 |
suppressed |
1 |
|
found |
15 |
| particles |
1 |
islet |
1 |
|
particularly |
1 |
every |
1 |
|
pathways |
15 |
| host |
1 |
dimensions |
1 |
|
assembled |
1 |
before |
1 |
|
used |
15 |
| reversible |
1 |
decitabine |
1 |
|
toxicants |
1 |
addicted |
1 |
|
states |
15 |
| into |
1 |
promoter |
1 |
|
unresponsive |
1 |
biased |
1 |
|
change |
15 |
| membrane |
1 |
understanding |
1 |
|
pet |
1 |
300 |
1 |
|
range |
15 |
| nanostructured |
1 |
corneas |
1 |
|
memory |
1 |
problem |
1 |
|
global |
15 |
| coli |
1 |
sites |
1 |
|
uniform |
1 |
feasible |
1 |
|
field |
15 |
| deltarg |
1 |
pigs |
1 |
|
brittle |
1 |
reaction |
1 |
|
populations |
14 |
| extremes |
1 |
island |
1 |
|
unclear |
1 |
virion |
1 |
|
rna |
14 |
| frontal |
1 |
transitions |
1 |
|
downhill |
1 |
great |
1 |
|
biology |
14 |
| psma |
1 |
begins |
1 |
|
formula |
1 |
discordant |
1 |
|
selective |
14 |
| i |
1 |
lesions |
1 |
|
specified |
1 |
non |
1 |
|
growth |
14 |
| 1616cm |
1 |
handers |
1 |
|
diploid |
1 |
aligned |
1 |
|
dynamics |
14 |
| deletion |
1 |
solution |
1 |
|
temporally |
1 |
77 |
1 |
|
processes |
14 |
| ifnlambda2 |
1 |
water |
1 |
|
permanently |
1 |
salient |
1 |
|
system |
14 |
| mode |
1 |
insult |
1 |
|
host |
1 |
obvious |
1 |
|
future |
14 |
| representations |
1 |
offsprings |
1 |
|
mature |
1 |
deleterious |
1 |
|
novel |
14 |
| melanoma |
1 |
exo1 |
1 |
|
unimportant |
1 |
approach |
1 |
|
major |
14 |
| proteolytic |
1 |
majority |
1 |
|
softer |
1 |
tracers |
1 |
|
severe |
14 |
| times |
1 |
inhibitor |
1 |
|
among |
1 |
b |
1 |
|
effective |
14 |
| 3 |
1 |
h2o |
1 |
|
and |
1 |
impaired |
1 |
|
model |
14 |
| million |
1 |
worsening |
1 |
|
hyperactivated |
1 |
determinant |
1 |
|
diverse |
14 |
| such |
1 |
osteoblasts |
1 |
|
transfusion |
1 |
surrogate |
1 |
|
larger |
14 |
| regulator |
1 |
brains |
1 |
|
blurred |
1 |
using |
1 |
|
resistance |
14 |
| bacteria |
1 |
mpfc |
1 |
|
ifn |
1 |
optimized |
1 |
|
showed |
14 |
| state |
1 |
by |
1 |
|
vulnerable |
1 |
useful |
1 |
|
leading |
14 |
| consequence |
1 |
together |
1 |
|
overt |
1 |
see |
1 |
|
signaling |
14 |
| nash |
1 |
patterns |
1 |
|
addicted |
1 |
could |
1 |
|
some |
14 |
| variants |
1 |
leishmania |
1 |
|
red |
1 |
entrained |
1 |
|
increase |
14 |
| cns |
1 |
loc |
1 |
|
necrotic |
1 |
crucial |
1 |
|
effects |
14 |
| pfass |
1 |
energies |
1 |
|
targets |
1 |
workhorse |
1 |
|
understanding |
14 |
| fuel |
1 |
alphago |
1 |
|
sated |
1 |
silenced |
1 |
|
about |
14 |
| instead |
1 |
islands |
1 |
|
wetter |
1 |
t |
1 |
|
approach |
14 |
| oregano |
1 |
clusters |
1 |
|
ossified |
1 |
restricted |
1 |
|
cellular |
14 |
| beneficial |
1 |
newcomers |
1 |
|
utilized |
1 |
11 |
1 |
|
small |
14 |
| maps |
1 |
visits |
1 |
|
again |
1 |
preferred |
1 |
|
scale |
13 |
| nk |
1 |
use |
1 |
|
anoxic |
1 |
remain |
1 |
|
mass |
13 |
| droplet |
1 |
many |
1 |
|
env |
1 |
influential |
1 |
|
carbon |
13 |
| dna |
1 |
100g |
1 |
|
entrained |
1 |
independent |
1 |
|
lead |
13 |
| used |
1 |
timing |
1 |
|
detrimental |
1 |
repressed |
1 |
|
i |
13 |
| pace |
1 |
protein |
1 |
|
specialized |
1 |
responsive |
1 |
|
evident |
13 |
| impairment |
1 |
receptors |
1 |
|
acquainted |
1 |
cognizant |
1 |
|
p |
13 |
| dissolution |
1 |
levels |
1 |
|
rarer |
1 |
faster |
1 |
|
different |
13 |
| microvascular |
1 |
chdh |
1 |
|
dna |
1 |
adopted |
1 |
|
induced |
13 |
| concordant |
1 |
particles |
1 |
|
able |
1 |
providing |
1 |
|
significant |
13 |
| whenever |
1 |
technologies |
1 |
|
exceedingly |
1 |
organic |
1 |
|
being |
13 |
| cmri |
1 |
ebv |
1 |
|
compartmentalized |
1 |
smaller |
1 |
|
long |
13 |
| cyclization |
1 |
performance |
1 |
|
better |
1 |
altered |
1 |
|
b |
13 |
| clks |
1 |
3 |
1 |
|
its |
1 |
smeared |
1 |
|
rates |
13 |
| cross |
1 |
fhl |
1 |
|
poised |
1 |
n |
1 |
|
advances |
12 |
| selectivity |
1 |
length |
1 |
|
floaters |
1 |
majority |
1 |
|
techniques |
12 |
| measurement |
1 |
transcripts |
1 |
|
constitutively |
1 |
segregated |
1 |
|
key |
12 |
| cork |
1 |
easily |
1 |
|
da |
1 |
initiating |
1 |
|
fully |
12 |
| modifications |
1 |
countries |
1 |
|
later |
1 |
notorious |
1 |
|
essential |
12 |
| mug |
1 |
rnas |
1 |
|
practically |
1 |
commonplace |
1 |
|
mechanisms |
12 |
| rapidly |
1 |
wisdom |
1 |
|
immunodominant |
1 |
issue |
1 |
|
present |
12 |
| vhhs |
1 |
those |
1 |
|
reprogrammed |
1 |
commercially |
1 |
|
tools |
12 |
| microporous |
1 |
strain |
1 |
|
prohibitive |
1 |
interesting |
1 |
|
properties |
12 |
| rtns |
1 |
mutualism |
1 |
|
localised |
1 |
hypermutators |
1 |
|
network |
12 |
| selection |
1 |
imagery |
1 |
|
stably |
1 |
several |
1 |
|
clinical |
12 |
| fold |
1 |
panels |
1 |
|
harder |
1 |
decentralised |
1 |
|
dependent |
12 |
| novel |
1 |
kpro |
1 |
|
non |
1 |
allowing |
1 |
|
mechanism |
12 |
| electronics |
1 |
chromosomes |
1 |
|
amplified |
1 |
prototype |
1 |
|
size |
12 |
| mechanism |
1 |
strength |
1 |
|
ubiquitous |
1 |
electrophile |
1 |
|
single |
12 |
| differentiate |
1 |
tau |
1 |
|
comparable |
1 |
exhausted |
1 |
|
greater |
12 |
| genetic |
1 |
adduct |
1 |
|
inert |
1 |
deployed |
1 |
|
level |
12 |
| hsct |
1 |
igllambda |
1 |
|
far |
1 |
scarce |
1 |
|
develop |
12 |
| onset |
1 |
suddenly |
1 |
|
inaccessible |
1 |
connected |
1 |
|
mediated |
12 |
| temporal |
1 |
rgens |
1 |
|
defective |
1 |
tool |
1 |
|
region |
12 |
| nerve |
1 |
regions |
1 |
|
invisible |
1 |
approximations |
1 |
|
detection |
12 |
| turn |
1 |
inhibition |
1 |
|
adaptive |
1 |
own |
1 |
|
derived |
12 |
| repeats |
1 |
kidneys |
1 |
|
suitable |
1 |
construct |
1 |
|
regions |
12 |
| pet |
1 |
proteome |
1 |
|
normoglycemic |
1 |
diverse |
1 |
|
following |
12 |
| degrees |
1 |
lattice |
1 |
|
acidified |
1 |
enabling |
1 |
|
context |
12 |
| earlier |
1 |
chromophores |
1 |
|
actively |
1 |
signal |
1 |
|
discovery |
12 |
| resistivity |
1 |
metabolomics |
1 |
|
well |
1 |
early |
1 |
|
tumors |
12 |
| lfp |
1 |
recipients |
1 |
|
technically |
1 |
good |
1 |
|
neurons |
12 |
| oct |
1 |
signal |
1 |
|
mzb |
1 |
larger |
1 |
|
powerful |
12 |
| context |
1 |
antioxidant |
1 |
|
recombined |
1 |
inactive |
1 |
|
genomic |
12 |
| itself |
1 |
phagosomes |
1 |
|
irrelevant |
1 |
proliferate |
1 |
|
exposure |
12 |
| devils |
1 |
signaling |
1 |
|
malignant |
1 |
grow |
1 |
|
heart |
12 |
| selections |
1 |
arm |
1 |
|
globally |
1 |
stringent |
1 |
|
biological |
12 |
| without |
1 |
cessation |
1 |
|
future |
1 |
alternate |
1 |
|
susceptible |
12 |
| vivipara |
1 |
therapies |
1 |
|
bactericidal |
1 |
algal |
1 |
|
primary |
11 |
| kocvs |
1 |
centers |
1 |
|
linear |
1 |
synaptic |
1 |
|
dna |
11 |
| regimens |
1 |
completely |
1 |
|
shorter |
1 |
products |
1 |
|
community |
11 |
| amino |
1 |
droughts |
1 |
|
fearful |
1 |
climate |
1 |
|
cost |
11 |
| podocytes |
1 |
mouse |
1 |
|
limiting |
1 |
interdependent |
1 |
|
light |
11 |
| desorption |
1 |
antigens |
1 |
|
amorphous |
1 |
inorganic |
1 |
|
pressure |
11 |
| capacity |
1 |
yields |
1 |
|
interconnected |
1 |
functional |
1 |
|
area |
11 |
| solids |
1 |
mof |
1 |
|
audible |
1 |
essential |
1 |
|
reaction |
11 |
| biospecimens |
1 |
melt |
1 |
|
energetically |
1 |
less |
1 |
|
targeted |
11 |
| bvgas |
1 |
authorities |
1 |
|
unmistakable |
1 |
long |
1 |
|
critical |
11 |
| lung |
1 |
dissipation |
1 |
|
too |
1 |
agonist |
1 |
|
role |
11 |
| myeloid |
1 |
compensation |
1 |
|
aware |
1 |
nucleophilic |
1 |
|
blood |
11 |
| colonies |
1 |
symptoms |
1 |
|
severe |
1 |
adept |
1 |
|
visual |
11 |
| embryonic |
1 |
agnathans |
1 |
|
cyclostomes |
1 |
extreme |
1 |
|
increases |
11 |
| wall |
1 |
things |
1 |
|
labile |
1 |
a |
1 |
|
mortality |
11 |
| procedure |
1 |
time |
1 |
|
complex |
1 |
marked |
1 |
|
likely |
11 |
| mtert |
1 |
hearts |
1 |
|
wheelchair |
1 |
pervasive |
1 |
|
food |
11 |
| time |
1 |
valleys |
1 |
|
totally |
1 |
therapies |
1 |
|
activity |
11 |
| mouse |
1 |
ratios |
1 |
|
real |
1 |
ordered |
1 |
|
method |
11 |
| scientists |
1 |
loci |
1 |
|
biased |
1 |
metastable |
1 |
|
individual |
11 |
| grouping |
1 |
evar |
1 |
|
immortalized |
1 |
established |
1 |
|
need |
11 |
| saprotrophic |
1 |
flour |
1 |
|
intermixed |
1 |
polar |
1 |
|
part |
11 |
| neurological |
1 |
vinegar |
1 |
|
receptive |
1 |
available |
1 |
|
particularly |
11 |
| likelihood |
1 |
microgastrinae |
1 |
|
most |
1 |
so |
1 |
|
beta |
11 |
| transient |
1 |
endocytosis |
1 |
|
dwarf |
1 |
within |
1 |
|
therapeutic |
11 |
| membranes |
1 |
behaviors |
1 |
|
linguistic |
1 |
reliable |
1 |
|
vivo |
11 |
| beta |
1 |
qmt |
1 |
|
intermittently |
1 |
oxymoron |
1 |
|
period |
11 |
| metalation |
1 |
relationship |
1 |
|
trapped |
1 |
understood |
1 |
|
formula |
11 |
| collisions |
1 |
novae |
1 |
|
lethal |
1 |
disconnected |
1 |
|
see |
11 |
| mice |
1 |
systems |
1 |
|
quiescent |
1 |
acute |
1 |
|
text |
11 |
| cagy |
1 |
epithelium |
1 |
|
th2 |
1 |
circular |
1 |
|
evidence |
11 |
| fusion |
1 |
plates |
1 |
|
polarized |
1 |
stabilized |
1 |
|
do |
11 |
| escs |
1 |
unfavorable |
1 |
|
largely |
1 |
indications |
1 |
|
demonstrate |
11 |
| jamming |
1 |
mutants |
1 |
|
weaker |
1 |
killed |
1 |
|
known |
11 |
| electrophysiological |
1 |
fibres |
1 |
|
imminent |
1 |
these |
1 |
|
association |
10 |
| progeny |
1 |
gata3 |
1 |
|
ideal |
1 |
throughout |
1 |
|
spectrometry |
10 |
| one |
1 |
sources |
1 |
|
intersex |
1 |
crowded |
1 |
|
changes |
10 |
| budesonide |
1 |
ultimately |
1 |
|
fertilized |
1 |
intensive |
1 |
|
areas |
10 |
| instantaneous |
1 |
polyq |
1 |
|
procoagulant |
1 |
fraction |
1 |
|
agents |
10 |
| river |
1 |
fertilization |
1 |
|
symptomatic |
1 |
treatment |
1 |
|
rate |
10 |
| traumatic |
1 |
progenitors |
1 |
|
routine |
1 |
complete |
1 |
|
independent |
10 |
| stage |
1 |
events |
1 |
|
tractable |
1 |
which |
1 |
|
form |
10 |
| rejuvenated |
1 |
mesenchyme |
1 |
|
coupled |
1 |
dependent |
1 |
|
molecules |
10 |
| network |
1 |
kir |
1 |
|
desensitized |
1 |
empty |
1 |
|
stage |
10 |
| results |
1 |
medicine |
1 |
|
pharmacological |
1 |
world |
1 |
|
central |
10 |
| lines |
1 |
future |
1 |
|
pathological |
1 |
real |
1 |
|
e |
10 |
| obesity |
1 |
when |
1 |
|
in |
1 |
diversified |
1 |
|
widespread |
10 |
| pde4 |
1 |
females |
1 |
|
equalized |
1 |
facile |
1 |
|
gene |
10 |
| beyond |
1 |
membranes |
1 |
|
ecological |
1 |
novae |
1 |
|
support |
10 |
| models |
1 |
betaars |
1 |
|
quickly |
1 |
polarized |
1 |
|
interaction |
10 |
| options |
1 |
stk1 |
1 |
|
obese |
1 |
contaminated |
1 |
|
diseases |
10 |
| birds |
1 |
experiences |
1 |
|
enhanced |
1 |
unfavorable |
1 |
|
hiv |
10 |
| diverged |
1 |
stimuli |
1 |
|
synchronized |
1 |
urgent |
1 |
|
sex |
10 |
| toolboxes |
1 |
memories |
1 |
|
cancerous |
1 |
like |
1 |
|
materials |
10 |
| nmr |
1 |
th |
1 |
|
insoluble |
1 |
convenient |
1 |
|
neural |
10 |
| vertebrate |
1 |
csr2 |
1 |
|
ypn0 |
1 |
de |
1 |
|
ability |
10 |
| stretches |
1 |
otus |
1 |
|
notable |
1 |
appealing |
1 |
|
activation |
10 |
| illnesses |
1 |
now |
1 |
|
actual |
1 |
order |
1 |
|
very |
10 |
| fields |
1 |
mitoneet |
1 |
|
primed |
1 |
unstructured |
1 |
|
even |
10 |
| user |
1 |
chromatin |
1 |
|
irreversibly |
1 |
broadly |
1 |
|
viruses |
10 |
| hsrs |
1 |
niches |
1 |
|
ecologically |
1 |
candidates |
1 |
|
without |
10 |
| activities |
1 |
mdc |
1 |
|
norms |
1 |
possessing |
1 |
|
contrast |
10 |
| resistance |
1 |
hfd |
1 |
|
unfavorable |
1 |
clear |
1 |
|
sensitivity |
10 |
| stitched |
1 |
activation |
1 |
|
interferences |
1 |
advance |
1 |
|
across |
10 |
| supercapacitors |
1 |
vessels |
1 |
|
uncontrolled |
1 |
polymerized |
1 |
|
genes |
10 |
| bandwidth |
1 |
transplantation |
1 |
|
deprotonated |
1 |
pressing |
1 |
|
chemical |
10 |
| layer |
1 |
travel |
1 |
|
fluorescent |
1 |
agents |
1 |
|
growing |
10 |
| framework |
1 |
rarely |
1 |
|
cystic |
1 |
mainly |
1 |
|
via |
10 |
| processes |
1 |
features |
1 |
|
superior |
1 |
tetrahedral |
1 |
|
isolated |
10 |
| complex |
1 |
case |
1 |
|
desynchronized |
1 |
rapid |
1 |
|
factors |
10 |
| better |
1 |
goethite |
1 |
|
transiently |
1 |
frequently |
1 |
|
frequent |
10 |
| tek |
1 |
pam3 |
1 |
|
reinfected |
1 |
premier |
1 |
|
survival |
10 |
| particular |
1 |
effects |
1 |
|
similarly |
1 |
50 |
1 |
|
free |
10 |
| ai |
1 |
c |
1 |
|
recognized |
1 |
clinically |
1 |
|
weeks |
10 |
| ordered |
1 |
kpc |
1 |
|
nagarkurnool |
1 |
growing |
1 |
|
diagnosis |
10 |
| resistant |
1 |
information |
1 |
|
hydrophobic |
1 |
generalists |
1 |
|
electron |
10 |
| occupied |
1 |
segregation |
1 |
|
small |
1 |
ineffective |
1 |
|
phase |
10 |
| feeder |
1 |
dennd3 |
1 |
|
cleared |
1 |
mature |
1 |
|
among |
10 |
| drug |
1 |
soon |
1 |
|
overshadowed |
1 |
20 |
1 |
|
management |
10 |
| stat |
1 |
compression |
1 |
|
obscured |
1 |
fibrotic |
1 |
|
drugs |
10 |
| registration |
1 |
frequently |
1 |
|
indistinguishable |
1 |
do |
1 |
|
widely |
10 |
| 0g |
1 |
moieties |
1 |
|
obsolete |
1 |
malignant |
1 |
|
participants |
10 |
| tcs |
1 |
song |
1 |
|
favored |
1 |
organ |
1 |
|
age |
10 |
| up |
1 |
flux |
1 |
|
unproductive |
1 |
chemoresistant |
1 |
|
three |
10 |
| solubilized |
1 |
format |
1 |
|
inflamed |
1 |
residues |
1 |
|
social |
10 |
| occasionally |
1 |
decision |
1 |
|
stressed |
1 |
used |
1 |
|
strategy |
9 |
| patch |
1 |
mechanisms |
1 |
|
generic |
1 |
water |
1 |
|
patient |
9 |
| dedifferentiate |
1 |
pericytes |
1 |
|
similar |
1 |
trapped |
1 |
|
allowed |
9 |
| mda |
1 |
ii |
1 |
|
delayed |
1 |
national |
1 |
|
conformation |
9 |
| verge |
1 |
ecp |
1 |
|
broad |
1 |
endemic |
1 |
|
alternative |
9 |
| cytoplasmic |
1 |
connections |
1 |
|
hcc |
1 |
predictable |
1 |
|
organic |
9 |
| inhomogeneity |
1 |
stewardship |
1 |
|
insufficient |
1 |
has |
1 |
|
maturation |
9 |
| scaffolds |
1 |
cjkt |
1 |
|
65 |
1 |
efficient |
1 |
|
pathogens |
9 |
| pbp |
1 |
decisions |
1 |
|
selectively |
1 |
standardised |
1 |
|
bacterial |
9 |
| art |
1 |
abundance |
1 |
|
appreciable |
1 |
features |
1 |
|
unclear |
9 |
| bodies |
1 |
20 |
1 |
|
warmer |
1 |
while |
1 |
|
chain |
9 |
| zika |
1 |
testing |
1 |
|
depolarized |
1 |
stereotyped |
1 |
|
fast |
9 |
| using |
1 |
genes |
1 |
|
unsustainable |
1 |
actively |
1 |
|
improved |
9 |
| sessile |
1 |
diverticulae |
1 |
|
saturated |
1 |
spatially |
1 |
|
demonstrated |
9 |
| what |
1 |
fluids |
1 |
|
incurable |
1 |
resistant |
1 |
|
learning |
9 |
| computing |
1 |
processes |
1 |
|
compromised |
1 |
models |
1 |
|
last |
9 |
| aggregate |
1 |
ezetimibe |
1 |
|
electronically |
1 |
technique |
1 |
|
decade |
9 |
| shedding |
1 |
carcinomas |
1 |
|
mothers |
1 |
instrumental |
1 |
|
expected |
9 |
| derived |
1 |
naturally |
1 |
|
insignificant |
1 |
district |
1 |
|
transition |
9 |
| not |
1 |
inputs |
1 |
|
positive |
1 |
34 |
1 |
|
line |
9 |
| developing |
1 |
film |
1 |
|
macrophages |
1 |
rectified |
1 |
|
decreased |
9 |
| radiation |
1 |
region |
1 |
|
strategically |
1 |
mandatory |
1 |
|
once |
9 |
| repurposing |
1 |
tolerance |
1 |
|
evidence |
1 |
over |
1 |
|
similar |
9 |
| essential |
1 |
folding |
1 |
|
hiv |
1 |
procedure |
1 |
|
mouse |
9 |
| soil |
1 |
gcs |
1 |
|
stalkophilic |
1 |
promising |
1 |
|
established |
9 |
| studies |
1 |
radius |
1 |
|
commensurate |
1 |
errorful |
1 |
|
quantum |
9 |
| 1970s |
1 |
inevitably |
1 |
|
extremely |
1 |
members |
1 |
|
performance |
9 |
| same |
1 |
hippocampus |
1 |
|
obstructed |
1 |
practice |
1 |
|
able |
9 |
| inequalities |
1 |
floods |
1 |
|
catastrophic |
1 |
correlated |
1 |
|
relative |
9 |
| digital |
1 |
monomer |
1 |
|
yellow |
1 |
resulting |
1 |
|
target |
9 |
| galactose |
1 |
progeny |
1 |
|
affiliative |
1 |
weak |
1 |
|
lung |
9 |
| flow |
1 |
glc |
1 |
|
silent |
1 |
years |
1 |
|
prominent |
9 |
| homologous |
1 |
toward |
1 |
|
suboptimal |
1 |
labile |
1 |
|
concentrations |
9 |
| how |
1 |
baseline |
1 |
|
strong |
1 |
targeted |
1 |
|
transplantation |
9 |
| similar |
1 |
ties |
1 |
|
imbalanced |
1 |
potential |
1 |
|
acid |
9 |
| biodiversity |
1 |
gas |
1 |
|
tilted |
1 |
sensitivity |
1 |
|
often |
9 |
| exo |
1 |
boundary |
1 |
|
entangled |
1 |
biocatalysts |
1 |
|
mutations |
9 |
| dissociation |
1 |
frequencies |
1 |
|
human |
1 |
species |
1 |
|
adaptation |
9 |
| hgf |
1 |
artery |
1 |
|
severely |
1 |
perturbed |
1 |
|
throughout |
9 |
| cost |
1 |
order |
1 |
|
psychiatrists |
1 |
challenging |
1 |
|
rise |
9 |
| materials |
1 |
warming |
1 |
|
epidemic |
1 |
invasive |
1 |
|
life |
9 |
| allergies |
1 |
leaves |
1 |
|
further |
1 |
due |
1 |
|
stress |
9 |
| stability |
1 |
animals |
1 |
|
potent |
1 |
fully |
1 |
|
binding |
9 |
| dynamics |
1 |
progressively |
1 |
|
educated |
1 |
below |
1 |
|
no |
9 |
| resolution |
1 |
response |
1 |
|
organized |
1 |
unfamiliar |
1 |
|
year |
9 |
| odds |
1 |
potentially |
1 |
|
sensitized |
1 |
recognized |
1 |
|
effect |
9 |
| mutualist |
1 |
interaction |
1 |
|
symptom |
1 |
genetically |
1 |
|
did |
9 |
| model |
1 |
rates |
1 |
|
appreciated |
1 |
precise |
1 |
|
order |
9 |
| poised |
1 |
octahedra |
1 |
|
ruffled |
1 |
routine |
1 |
|
memory |
9 |
| experiments |
1 |
p2 |
1 |
|
closer |
1 |
basal |
1 |
|
whereas |
9 |
| pdxs |
1 |
prx2 |
1 |
|
home |
1 |
matter |
1 |
|
same |
9 |
| removed |
1 |
daas |
1 |
|
distributed |
1 |
pandemic |
1 |
|
short |
9 |
| denitrification |
1 |
hdac3 |
1 |
|
preferable |
1 |
hypothermic |
1 |
|
networks |
9 |
| probiotics |
1 |
evolution |
1 |
|
preferentially |
1 |
are |
1 |
|
inflammatory |
9 |
| injection |
1 |
viruses |
1 |
|
easily |
1 |
binocular |
1 |
|
differences |
9 |
| genome |
1 |
must |
1 |
|
layers |
1 |
intense |
1 |
|
environment |
9 |
| support |
1 |
energy |
1 |
|
necessary |
1 |
cost |
1 |
|
treated |
9 |
| analyses |
1 |
sharing |
1 |
|
damaged |
1 |
median |
1 |
|
previously |
9 |
| reactivity |
1 |
topologies |
1 |
|
completely |
1 |
above |
1 |
|
prevalent |
9 |
| may |
1 |
wiring |
1 |
|
inextricably |
1 |
suggesting |
1 |
|
viral |
9 |
| sno |
1 |
oxidation |
1 |
|
upregulated |
1 |
fragmented |
1 |
|
limited |
9 |
| sp |
1 |
norm |
1 |
|
recombination |
1 |
about |
1 |
|
stronger |
9 |
| icb |
1 |
likely |
1 |
|
state |
1 |
end |
1 |
|
popular |
9 |
| targets |
1 |
axon |
1 |
|
high |
1 |
based |
1 |
|
since |
9 |
| viruses |
1 |
women |
1 |
|
overwhelmed |
1 |
suppressive |
1 |
|
toward |
9 |
| outcomes |
1 |
sexes |
1 |
|
excessively |
1 |
concentrated |
1 |
|
female |
9 |
| conditions |
1 |
densities |
1 |
|
supplemented |
1 |
recently |
1 |
|
dominant |
9 |
| spectroscopy |
1 |
areas |
1 |
|
engulfed |
1 |
ketotic |
1 |
|
impact |
9 |
| continued |
1 |
south |
1 |
|
brighter |
1 |
bioenergy |
1 |
|
prior |
8 |
| isolated |
1 |
structure |
1 |
|
synonymous |
1 |
area |
1 |
|
wide |
8 |
| based |
1 |
mice |
1 |
|
perpendicular |
1 |
inactivated |
1 |
|
quantitative |
8 |
| 5 |
1 |
occidentalis |
1 |
|
epithelioid |
1 |
detectable |
1 |
|
routine |
8 |
| repellant |
1 |
tfs |
1 |
|
dwarfed |
1 |
insignificant |
1 |
|
approaches |
8 |
| because |
1 |
finally |
1 |
|
|
|
unoccupied |
1 |
|
specifically |
8 |
| wnd |
1 |
ybal3 |
1 |
|
|
|
itinerant |
1 |
|
particles |
8 |
| 4ht |
1 |
states |
1 |
|
|
|
drugs |
1 |
|
evolved |
8 |
| humans |
1 |
transport |
1 |
|
|
|
interwoven |
1 |
|
therefore |
8 |
| targeted |
1 |
occurred |
1 |
|
|
|
hotspots |
1 |
|
40 |
8 |
| undergoes |
1 |
infections |
1 |
|
|
|
substrate |
1 |
|
source |
8 |
| white |
1 |
pertuzumab |
1 |
|
|
|
permeable |
1 |
|
zikv |
8 |
| domain |
1 |
i |
1 |
|
|
|
clearer |
1 |
|
months |
8 |
| subclones |
1 |
ngr |
1 |
|
|
|
flexible |
1 |
|
findings |
8 |
| situations |
1 |
chain |
1 |
|
|
|
60 |
1 |
|
yet |
8 |
| respiration |
1 |
barrier |
1 |
|
|
|
|
|
|
pregnant |
8 |
| graphical |
1 |
dots |
1 |
|
|
|
|
|
|
times |
8 |
| droughts |
1 |
peptide |
1 |
|
|
|
|
|
|
matter |
8 |
| resident |
1 |
first |
1 |
|
|
|
|
|
|
tissues |
8 |
| d50 |
1 |
relaxation |
1 |
|
|
|
|
|
|
invasive |
8 |
| effort |
1 |
|
|
|
|
|
|
|
|
especially |
8 |
| ability |
1 |
|
|
|
|
|
|
|
|
ever |
8 |
| observer |
1 |
|
|
|
|
|
|
|
|
approximately |
8 |
| chf |
1 |
|
|
|
|
|
|
|
|
male |
8 |
| vlse |
1 |
|
|
|
|
|
|
|
|
importance |
8 |
| fail |
1 |
|
|
|
|
|
|
|
|
availability |
8 |
| energy |
1 |
|
|
|
|
|
|
|
|
nm |
8 |
| some |
1 |
|
|
|
|
|
|
|
|
problem |
8 |
| stimuli |
1 |
|
|
|
|
|
|
|
|
ca |
8 |
| superlattice |
1 |
|
|
|
|
|
|
|
|
g |
8 |
| stroke |
1 |
|
|
|
|
|
|
|
|
each |
8 |
| epithelial |
1 |
|
|
|
|
|
|
|
|
components |
8 |
| research |
1 |
|
|
|
|
|
|
|
|
medical |
8 |
| photoprotective |
1 |
|
|
|
|
|
|
|
|
great |
8 |
| syria |
1 |
|
|
|
|
|
|
|
|
magnetic |
8 |
| ablation |
1 |
|
|
|
|
|
|
|
|
despite |
8 |
| might |
1 |
|
|
|
|
|
|
|
|
group |
8 |
| caenorhabditis |
1 |
|
|
|
|
|
|
|
|
formation |
8 |
| over |
1 |
|
|
|
|
|
|
|
|
rapid |
8 |
| years |
1 |
|
|
|
|
|
|
|
|
diffusion |
8 |
| regenerative |
1 |
|
|
|
|
|
|
|
|
technique |
8 |
| algal |
1 |
|
|
|
|
|
|
|
|
promising |
8 |
| addiction |
1 |
|
|
|
|
|
|
|
|
must |
8 |
| cko |
1 |
|
|
|
|
|
|
|
|
required |
8 |
| development |
1 |
|
|
|
|
|
|
|
|
resolution |
8 |
| selected |
1 |
|
|
|
|
|
|
|
|
quickly |
8 |
| snacking |
1 |
|
|
|
|
|
|
|
|
density |
8 |
| rci |
1 |
|
|
|
|
|
|
|
|
later |
8 |
| teff |
1 |
|
|
|
|
|
|
|
|
becomes |
8 |
| investment |
1 |
|
|
|
|
|
|
|
|
difficult |
8 |
| information |
1 |
|
|
|
|
|
|
|
|
tumor |
8 |
| cas9 |
1 |
|
|
|
|
|
|
|
|
world |
8 |
| to |
1 |
|
|
|
|
|
|
|
|
soil |
8 |
| independent |
1 |
|
|
|
|
|
|
|
|
technologies |
8 |
| online |
1 |
|
|
|
|
|
|
|
|
suggesting |
8 |
| old |
1 |
|
|
|
|
|
|
|
|
rats |
8 |
| nonlinguistic |
1 |
|
|
|
|
|
|
|
|
furthermore |
7 |
| left |
1 |
|
|
|
|
|
|
|
|
samples |
7 |
| indications |
1 |
|
|
|
|
|
|
|
|
past |
7 |
| anaerobic |
1 |
|
|
|
|
|
|
|
|
suggests |
7 |
| there |
1 |
|
|
|
|
|
|
|
|
art |
7 |
| splicing |
1 |
|
|
|
|
|
|
|
|
identify |
7 |
| steel |
1 |
|
|
|
|
|
|
|
|
applications |
7 |
| mossy |
1 |
|
|
|
|
|
|
|
|
reduced |
7 |
| modeling |
1 |
|
|
|
|
|
|
|
|
targets |
7 |
| cycle |
1 |
|
|
|
|
|
|
|
|
targeting |
7 |
| factor |
1 |
|
|
|
|
|
|
|
|
revealed |
7 |
| absorb |
1 |
|
|
|
|
|
|
|
|
applied |
7 |
| nitrogen |
1 |
|
|
|
|
|
|
|
|
remains |
7 |
| states |
1 |
|
|
|
|
|
|
|
|
negative |
7 |
| sections |
1 |
|
|
|
|
|
|
|
|
communities |
7 |
| conducting |
1 |
|
|
|
|
|
|
|
|
cortex |
7 |
| relations |
1 |
|
|
|
|
|
|
|
|
coronary |
7 |
| rop |
1 |
|
|
|
|
|
|
|
|
disorders |
7 |
| endocytosis |
1 |
|
|
|
|
|
|
|
|
valuable |
7 |
| mirnas |
1 |
|
|
|
|
|
|
|
|
degrees |
7 |
| fibrillation |
1 |
|
|
|
|
|
|
|
|
solution |
7 |
| multipotent |
1 |
|
|
|
|
|
|
|
|
deletion |
7 |
| wave |
1 |
|
|
|
|
|
|
|
|
h |
7 |
| duct |
1 |
|
|
|
|
|
|
|
|
hippocampal |
7 |
| nkg2a |
1 |
|
|
|
|
|
|
|
|
differentiation |
7 |
| competent |
1 |
|
|
|
|
|
|
|
|
women |
7 |
| fep |
1 |
|
|
|
|
|
|
|
|
quality |
7 |
| precision |
1 |
|
|
|
|
|
|
|
|
combination |
7 |
| undergo |
1 |
|
|
|
|
|
|
|
|
cardiac |
7 |
| thus |
1 |
|
|
|
|
|
|
|
|
antibodies |
7 |
| genetics |
1 |
|
|
|
|
|
|
|
|
shift |
7 |
| oscillations |
1 |
|
|
|
|
|
|
|
|
related |
7 |
| machinery |
1 |
|
|
|
|
|
|
|
|
digital |
7 |
| receptors |
1 |
|
|
|
|
|
|
|
|
focus |
7 |
| lacking |
1 |
|
|
|
|
|
|
|
|
sea |
7 |
| phenotypes |
1 |
|
|
|
|
|
|
|
|
point |
7 |
| ambient |
1 |
|
|
|
|
|
|
|
|
progression |
7 |
| defects |
1 |
|
|
|
|
|
|
|
|
synaptic |
7 |
| psychotic |
1 |
|
|
|
|
|
|
|
|
potentially |
7 |
| kits |
1 |
|
|
|
|
|
|
|
|
normal |
7 |
| use |
1 |
|
|
|
|
|
|
|
|
positive |
7 |
| prone |
1 |
|
|
|
|
|
|
|
|
fluorescence |
7 |
| environmental |
1 |
|
|
|
|
|
|
|
|
synthesis |
7 |
| reactivated |
1 |
|
|
|
|
|
|
|
|
indicate |
7 |
| system |
1 |
|
|
|
|
|
|
|
|
challenge |
7 |
| pembrolizumab |
1 |
|
|
|
|
|
|
|
|
resonance |
7 |
| should |
1 |
|
|
|
|
|
|
|
|
subsequently |
7 |
| rnap |
1 |
|
|
|
|
|
|
|
|
variability |
7 |
| parental |
1 |
|
|
|
|
|
|
|
|
evolutionary |
7 |
| cortex |
1 |
|
|
|
|
|
|
|
|
lacking |
7 |
| engram |
1 |
|
|
|
|
|
|
|
|
remained |
7 |
| an |
1 |
|
|
|
|
|
|
|
|
production |
7 |
| tissue |
1 |
|
|
|
|
|
|
|
|
anti |
7 |
| images |
1 |
|
|
|
|
|
|
|
|
factor |
7 |
| karyotypes |
1 |
|
|
|
|
|
|
|
|
limitation |
7 |
| fba |
1 |
|
|
|
|
|
|
|
|
medicine |
7 |
| retinal |
1 |
|
|
|
|
|
|
|
|
throughput |
7 |
| international |
1 |
|
|
|
|
|
|
|
|
emerging |
7 |
| lesions |
1 |
|
|
|
|
|
|
|
|
days |
7 |
| fine |
1 |
|
|
|
|
|
|
|
|
30 |
7 |
| 119 |
1 |
|
|
|
|
|
|
|
|
failure |
7 |
| organocatalysis |
1 |
|
|
|
|
|
|
|
|
cortical |
7 |
| manipulation |
1 |
|
|
|
|
|
|
|
|
death |
7 |
| every |
1 |
|
|
|
|
|
|
|
|
strain |
7 |
| tend |
1 |
|
|
|
|
|
|
|
|
mature |
7 |
| transpeptidase |
1 |
|
|
|
|
|
|
|
|
compared |
7 |
| nanoparticulate |
1 |
|
|
|
|
|
|
|
|
95 |
7 |
| tec |
1 |
|
|
|
|
|
|
|
|
ci |
7 |
| markers |
1 |
|
|
|
|
|
|
|
|
liquid |
7 |
| phospholipase |
1 |
|
|
|
|
|
|
|
|
receptors |
7 |
| previously |
1 |
|
|
|
|
|
|
|
|
produce |
7 |
| slums |
1 |
|
|
|
|
|
|
|
|
current |
7 |
| subtype |
1 |
|
|
|
|
|
|
|
|
threat |
7 |
| nurse |
1 |
|
|
|
|
|
|
|
|
m |
7 |
| tests |
1 |
|
|
|
|
|
|
|
|
stem |
7 |
| phenol |
1 |
|
|
|
|
|
|
|
|
like |
7 |
| also |
1 |
|
|
|
|
|
|
|
|
sites |
7 |
| microbiome |
1 |
|
|
|
|
|
|
|
|
structural |
7 |
| five |
1 |
|
|
|
|
|
|
|
|
types |
7 |
| earth |
1 |
|
|
|
|
|
|
|
|
expressed |
7 |
| manner |
1 |
|
|
|
|
|
|
|
|
outcomes |
7 |
| males |
1 |
|
|
|
|
|
|
|
|
majority |
7 |
| predisposed |
1 |
|
|
|
|
|
|
|
|
radiation |
7 |
| substrate |
1 |
|
|
|
|
|
|
|
|
western |
7 |
| encounters |
1 |
|
|
|
|
|
|
|
|
events |
7 |
| plate |
1 |
|
|
|
|
|
|
|
|
indicating |
7 |
| quorum |
1 |
|
|
|
|
|
|
|
|
understand |
7 |
| uad |
1 |
|
|
|
|
|
|
|
|
generation |
7 |
| clocks |
1 |
|
|
|
|
|
|
|
|
decades |
7 |
| consolidate |
1 |
|
|
|
|
|
|
|
|
000 |
7 |
| achieved |
1 |
|
|
|
|
|
|
|
|
fraction |
7 |
| pathogen |
1 |
|
|
|
|
|
|
|
|
fe |
7 |
| restriction |
1 |
|
|
|
|
|
|
|
|
assessment |
6 |
| would |
1 |
|
|
|
|
|
|
|
|
particular |
6 |
| additional |
1 |
|
|
|
|
|
|
|
|
site |
6 |
| oir |
1 |
|
|
|
|
|
|
|
|
procedure |
6 |
| flora |
1 |
|
|
|
|
|
|
|
|
ratio |
6 |
| mitoproteases |
1 |
|
|
|
|
|
|
|
|
symptoms |
6 |
| finch |
1 |
|
|
|
|
|
|
|
|
features |
6 |
| molecules |
1 |
|
|
|
|
|
|
|
|
transmission |
6 |
| transcriptomics |
1 |
|
|
|
|
|
|
|
|
conventional |
6 |
| those |
1 |
|
|
|
|
|
|
|
|
sensitive |
6 |
| mutt |
1 |
|
|
|
|
|
|
|
|
containing |
6 |
| transposon |
1 |
|
|
|
|
|
|
|
|
needed |
6 |
| er |
1 |
|
|
|
|
|
|
|
|
epithelial |
6 |
| activity |
1 |
|
|
|
|
|
|
|
|
involved |
6 |
| district |
1 |
|
|
|
|
|
|
|
|
accessible |
6 |
| excitatory |
1 |
|
|
|
|
|
|
|
|
capacity |
6 |
| tavr |
1 |
|
|
|
|
|
|
|
|
stable |
6 |
| antimicrobial |
1 |
|
|
|
|
|
|
|
|
adaptive |
6 |
| abgcs |
1 |
|
|
|
|
|
|
|
|
potent |
6 |
| imprint |
1 |
|
|
|
|
|
|
|
|
domain |
6 |
| flpa |
1 |
|
|
|
|
|
|
|
|
direct |
6 |
| replacement |
1 |
|
|
|
|
|
|
|
|
spatial |
6 |
| 32 |
1 |
|
|
|
|
|
|
|
|
representations |
6 |
| work |
1 |
|
|
|
|
|
|
|
|
determining |
6 |
| predictive |
1 |
|
|
|
|
|
|
|
|
ion |
6 |
| relative |
1 |
|
|
|
|
|
|
|
|
membranes |
6 |
| n |
1 |
|
|
|
|
|
|
|
|
mechanistic |
6 |
| prrt |
1 |
|
|
|
|
|
|
|
|
favorable |
6 |
| transplant |
1 |
|
|
|
|
|
|
|
|
x |
6 |
| chaetognaths |
1 |
|
|
|
|
|
|
|
|
prevalence |
6 |
| teeth |
1 |
|
|
|
|
|
|
|
|
sample |
6 |
| animal |
1 |
|
|
|
|
|
|
|
|
transcription |
6 |
| range |
1 |
|
|
|
|
|
|
|
|
worldwide |
6 |
| nafld |
1 |
|
|
|
|
|
|
|
|
crucial |
6 |
| enzymes |
1 |
|
|
|
|
|
|
|
|
now |
6 |
| hydrothermal |
1 |
|
|
|
|
|
|
|
|
groups |
6 |
| squamous |
1 |
|
|
|
|
|
|
|
|
motor |
6 |
| rhythms |
1 |
|
|
|
|
|
|
|
|
rather |
6 |
| k |
1 |
|
|
|
|
|
|
|
|
efficacy |
6 |
| technologies |
1 |
|
|
|
|
|
|
|
|
causing |
6 |
| interacting |
1 |
|
|
|
|
|
|
|
|
commonly |
6 |
| participants |
1 |
|
|
|
|
|
|
|
|
haploid |
6 |
| by |
1 |
|
|
|
|
|
|
|
|
selection |
6 |
| qpcr |
1 |
|
|
|
|
|
|
|
|
clinically |
6 |
| axon |
1 |
|
|
|
|
|
|
|
|
nk |
6 |
| flocs |
1 |
|
|
|
|
|
|
|
|
against |
6 |
| only |
1 |
|
|
|
|
|
|
|
|
compounds |
6 |
| set |
1 |
|
|
|
|
|
|
|
|
lower |
6 |
| disk |
1 |
|
|
|
|
|
|
|
|
extreme |
6 |
| yet |
1 |
|
|
|
|
|
|
|
|
evolution |
6 |
| yeast |
1 |
|
|
|
|
|
|
|
|
dynamic |
6 |
| metal |
1 |
|
|
|
|
|
|
|
|
channel |
6 |
| spring |
1 |
|
|
|
|
|
|
|
|
smaller |
6 |
| mitochondrial |
1 |
|
|
|
|
|
|
|
|
directly |
6 |
| biomolecules |
1 |
|
|
|
|
|
|
|
|
delivery |
6 |
| fluorine |
1 |
|
|
|
|
|
|
|
|
longer |
6 |
| treatments |
1 |
|
|
|
|
|
|
|
|
ineligible |
6 |
| resuscitation |
1 |
|
|
|
|
|
|
|
|
environmental |
6 |
| posterior |
1 |
|
|
|
|
|
|
|
|
treating |
6 |
| therapy |
1 |
|
|
|
|
|
|
|
|
metastatic |
6 |
| cvd |
1 |
|
|
|
|
|
|
|
|
20 |
6 |
| centrioles |
1 |
|
|
|
|
|
|
|
|
functions |
6 |
| promise |
1 |
|
|
|
|
|
|
|
|
acids |
6 |
| annealing |
1 |
|
|
|
|
|
|
|
|
occur |
6 |
| neutral |
1 |
|
|
|
|
|
|
|
|
suitable |
6 |
| gestation |
1 |
|
|
|
|
|
|
|
|
vitro |
6 |
| difficile |
1 |
|
|
|
|
|
|
|
|
component |
6 |
| powers |
1 |
|
|
|
|
|
|
|
|
intermediate |
6 |
| from |
1 |
|
|
|
|
|
|
|
|
explain |
6 |
| financial |
1 |
|
|
|
|
|
|
|
|
behaviors |
6 |
| technology |
1 |
|
|
|
|
|
|
|
|
efforts |
6 |
| natural |
1 |
|
|
|
|
|
|
|
|
temperatures |
6 |
| among |
1 |
|
|
|
|
|
|
|
|
own |
6 |
| phase |
1 |
|
|
|
|
|
|
|
|
chronic |
6 |
| organism |
1 |
|
|
|
|
|
|
|
|
organ |
6 |
| centers |
1 |
|
|
|
|
|
|
|
|
mixed |
6 |
| women |
1 |
|
|
|
|
|
|
|
|
shows |
6 |
| radial |
1 |
|
|
|
|
|
|
|
|
dementia |
6 |
| lphi |
1 |
|
|
|
|
|
|
|
|
81 |
6 |
| quickly |
1 |
|
|
|
|
|
|
|
|
prostate |
6 |
| orchestrated |
1 |
|
|
|
|
|
|
|
|
remain |
6 |
| wound |
1 |
|
|
|
|
|
|
|
|
organisms |
6 |
| tracing |
1 |
|
|
|
|
|
|
|
|
innate |
6 |
| talin |
1 |
|
|
|
|
|
|
|
|
injury |
6 |
| transplantation |
1 |
|
|
|
|
|
|
|
|
much |
6 |
| ultraviolet |
1 |
|
|
|
|
|
|
|
|
emergence |
6 |
| firing |
1 |
|
|
|
|
|
|
|
|
old |
6 |
| contrast |
1 |
|
|
|
|
|
|
|
|
macrophages |
6 |
| normal |
1 |
|
|
|
|
|
|
|
|
tuberculosis |
6 |
| carbon |
1 |
|
|
|
|
|
|
|
|
adult |
6 |
| asymptomatic |
1 |
|
|
|
|
|
|
|
|
topical |
6 |
| conformation |
1 |
|
|
|
|
|
|
|
|
becoming |
6 |
| types |
1 |
|
|
|
|
|
|
|
|
signals |
6 |
| required |
1 |
|
|
|
|
|
|
|
|
receptor |
6 |
| iavs |
1 |
|
|
|
|
|
|
|
|
simulations |
6 |
| oral |
1 |
|
|
|
|
|
|
|
|
declined |
6 |
| planning |
1 |
|
|
|
|
|
|
|
|
surgery |
6 |
| does |
1 |
|
|
|
|
|
|
|
|
inhibitors |
6 |
| r5 |
1 |
|
|
|
|
|
|
|
|
transport |
6 |
| assembly |
1 |
|
|
|
|
|
|
|
|
improvements |
6 |
| clearing |
1 |
|
|
|
|
|
|
|
|
technology |
6 |
| activation |
1 |
|
|
|
|
|
|
|
|
driving |
6 |
| distribution |
1 |
|
|
|
|
|
|
|
|
few |
6 |
| fgfr2 |
1 |
|
|
|
|
|
|
|
|
cd4 |
6 |
| possible |
1 |
|
|
|
|
|
|
|
|
nitrogen |
6 |
| dense |
1 |
|
|
|
|
|
|
|
|
reduce |
6 |
| monodonta |
1 |
|
|
|
|
|
|
|
|
kidney |
6 |
| country |
1 |
|
|
|
|
|
|
|
|
per |
6 |
| increase |
1 |
|
|
|
|
|
|
|
|
progressively |
6 |
| nitrite |
1 |
|
|
|
|
|
|
|
|
physical |
6 |
| injury |
1 |
|
|
|
|
|
|
|
|
term |
6 |
| foxp3 |
1 |
|
|
|
|
|
|
|
|
spectral |
6 |
| sensitivity |
1 |
|
|
|
|
|
|
|
|
second |
6 |
| eight |
1 |
|
|
|
|
|
|
|
|
l |
6 |
| both |
1 |
|
|
|
|
|
|
|
|
whole |
5 |
| inflammasome |
1 |
|
|
|
|
|
|
|
|
requires |
5 |
| urban |
1 |
|
|
|
|
|
|
|
|
traits |
5 |
| forced |
1 |
|
|
|
|
|
|
|
|
driven |
5 |
| honeycomb |
1 |
|
|
|
|
|
|
|
|
demand |
5 |
| mutant |
1 |
|
|
|
|
|
|
|
|
chemistry |
5 |
| f |
1 |
|
|
|
|
|
|
|
|
intensive |
5 |
| trichogramma |
1 |
|
|
|
|
|
|
|
|
optical |
5 |
| specific |
1 |
|
|
|
|
|
|
|
|
healthcare |
5 |
| all |
1 |
|
|
|
|
|
|
|
|
addition |
5 |
| subunits |
1 |
|
|
|
|
|
|
|
|
attractive |
5 |
| fa |
1 |
|
|
|
|
|
|
|
|
13 |
5 |
| invaded |
1 |
|
|
|
|
|
|
|
|
presence |
5 |
| isolation |
1 |
|
|
|
|
|
|
|
|
substrates |
5 |
| 4f |
1 |
|
|
|
|
|
|
|
|
issue |
5 |
| carrier |
1 |
|
|
|
|
|
|
|
|
infectious |
5 |
| fewer |
1 |
|
|
|
|
|
|
|
|
initially |
5 |
| introduced |
1 |
|
|
|
|
|
|
|
|
contact |
5 |
| transposase |
1 |
|
|
|
|
|
|
|
|
axons |
5 |
| antioxidant |
1 |
|
|
|
|
|
|
|
|
contribute |
5 |
| filtration |
1 |
|
|
|
|
|
|
|
|
treatments |
5 |
| fish |
1 |
|
|
|
|
|
|
|
|
liver |
5 |
| movements |
1 |
|
|
|
|
|
|
|
|
markers |
5 |
| them |
1 |
|
|
|
|
|
|
|
|
enhanced |
5 |
| fast |
1 |
|
|
|
|
|
|
|
|
oxygen |
5 |
| cardiomyopathies |
1 |
|
|
|
|
|
|
|
|
storage |
5 |
| needs |
1 |
|
|
|
|
|
|
|
|
self |
5 |
| space |
1 |
|
|
|
|
|
|
|
|
reduction |
5 |
|
|
|
|
|
|
|
|
|
|
complete |
5 |
|
|
|
|
|
|
|
|
|
|
suppressed |
5 |
|
|
|
|
|
|
|
|
|
|
every |
5 |
|
|
|
|
|
|
|
|
|
|
subsequent |
5 |
|
|
|
|
|
|
|
|
|
|
balance |
5 |
|
|
|
|
|
|
|
|
|
|
epidemic |
5 |
|
|
|
|
|
|
|
|
|
|
strategies |
5 |
|
|
|
|
|
|
|
|
|
|
flow |
5 |
|
|
|
|
|
|
|
|
|
|
significance |
5 |
|
|
|
|
|
|
|
|
|
|
option |
5 |
|
|
|
|
|
|
|
|
|
|
enzymes |
5 |
|
|
|
|
|
|
|
|
|
|
lifetime |
5 |
|
|
|
|
|
|
|
|
|
|
provide |
5 |
|
|
|
|
|
|
|
|
|
|
humans |
5 |
|
|
|
|
|
|
|
|
|
|
cause |
5 |
|
|
|
|
|
|
|
|
|
|
find |
5 |
|
|
|
|
|
|
|
|
|
|
conducting |
5 |
|
|
|
|
|
|
|
|
|
|
live |
5 |
|
|
|
|
|
|
|
|
|
|
underlying |
5 |
|
|
|
|
|
|
|
|
|
|
strength |
5 |
|
|
|
|
|
|
|
|
|
|
pathological |
5 |
|
|
|
|
|
|
|
|
|
|
stages |
5 |
|
|
|
|
|
|
|
|
|
|
defined |
5 |
|
|
|
|
|
|
|
|
|
|
living |
5 |
|
|
|
|
|
|
|
|
|
|
end |
5 |
|
|
|
|
|
|
|
|
|
|
concern |
5 |
|
|
|
|
|
|
|
|
|
|
pathogenic |
5 |
|
|
|
|
|
|
|
|
|
|
elements |
5 |
|
|
|
|
|
|
|
|
|
|
identity |
5 |
|
|
|
|
|
|
|
|
|
|
promote |
5 |
|
|
|
|
|
|
|
|
|
|
measure |
5 |
|
|
|
|
|
|
|
|
|
|
significantly |
5 |
|
|
|
|
|
|
|
|
|
|
gradually |
5 |
|
|
|
|
|
|
|
|
|
|
controlled |
5 |
|
|
|
|
|
|
|
|
|
|
lesions |
5 |
|
|
|
|
|
|
|
|
|
|
complications |
5 |
|
|
|
|
|
|
|
|
|
|
set |
5 |
|
|
|
|
|
|
|
|
|
|
ms |
5 |
|
|
|
|
|
|
|
|
|
|
currently |
5 |
|
|
|
|
|
|
|
|
|
|
white |
5 |
|
|
|
|
|
|
|
|
|
|
detected |
5 |
|
|
|
|
|
|
|
|
|
|
measuring |
5 |
|
|
|
|
|
|
|
|
|
|
intensity |
5 |
|
|
|
|
|
|
|
|
|
|
complexes |
5 |
|
|
|
|
|
|
|
|
|
|
overall |
5 |
|
|
|
|
|
|
|
|
|
|
structures |
5 |
|
|
|
|
|
|
|
|
|
|
replication |
5 |
|
|
|
|
|
|
|
|
|
|
modules |
5 |
|
|
|
|
|
|
|
|
|
|
open |
5 |
|
|
|
|
|
|
|
|
|
|
abundant |
5 |
|
|
|
|
|
|
|
|
|
|
making |
5 |
|
|
|
|
|
|
|
|
|
|
linear |
5 |
|
|
|
|
|
|
|
|
|
|
inhibition |
5 |
|
|
|
|
|
|
|
|
|
|
cross |
5 |
|
|
|
|
|
|
|
|
|
|
length |
5 |
|
|
|
|
|
|
|
|
|
|
previous |
5 |
|
|
|
|
|
|
|
|
|
|
behavior |
5 |
|
|
|
|
|
|
|
|
|
|
initial |
5 |
|
|
|
|
|
|
|
|
|
|
animal |
5 |
|
|
|
|
|
|
|
|
|
|
analyses |
5 |
|
|
|
|
|
|
|
|
|
|
devices |
5 |
|
|
|
|
|
|
|
|
|
|
stability |
5 |
|
|
|
|
|
|
|
|
|
|
recognized |
5 |
|
|
|
|
|
|
|
|
|
|
real |
5 |
|
|
|
|
|
|
|
|
|
|
average |
5 |
|
|
|
|
|
|
|
|
|
|
mutant |
5 |
|
|
|
|
|
|
|
|
|
|
products |
5 |
|
|
|
|
|
|
|
|
|
|
sequences |
5 |
|
|
|
|
|
|
|
|
|
|
procedures |
5 |
|
|
|
|
|
|
|
|
|
|
choice |
5 |
|
|
|
|
|
|
|
|
|
|
manner |
5 |
|
|
|
|
|
|
|
|
|
|
caused |
5 |
|
|
|
|
|
|
|
|
|
|
flexible |
5 |
|
|
|
|
|
|
|
|
|
|
characterization |
5 |
|
|
|
|
|
|
|
|
|
|
specificity |
5 |
|
|
|
|
|
|
|
|
|
|
variation |
5 |
|
|
|
|
|
|
|
|
|
|
induction |
5 |
|
|
|
|
|
|
|
|
|
|
distribution |
5 |
|
|
|
|
|
|
|
|
|
|
film |
5 |
|
|
|
|
|
|
|
|
|
|
decrease |
5 |
|
|
|
|
|
|
|
|
|
|
tg |
5 |
|
|
|
|
|
|
|
|
|
|
hypotheses |
5 |
|
|
|
|
|
|
|
|
|
|
phenotype |
5 |
|
|
|
|
|
|
|
|
|
|
predicted |
5 |
|
|
|
|
|
|
|
|
|
|
bound |
5 |
|
|
|
|
|
|
|
|
|
|
coupled |
5 |
|
|
|
|
|
|
|
|
|
|
trial |
5 |
|
|
|
|
|
|
|
|
|
|
molecule |
5 |
|
|
|
|
|
|
|
|
|
|
fitness |
5 |
|
|
|
|
|
|
|
|
|
|
normally |
5 |
|
|
|
|
|
|
|
|
|
|
restricted |
5 |
|
|
|
|
|
|
|
|
|
|
difference |
5 |
|
|
|
|
|
|
|
|
|
|
oral |
5 |
|
|
|
|
|
|
|
|
|
|
prevention |
5 |
|
|
|
|
|
|
|
|
|
|
improve |
5 |
|
|
|
|
|
|
|
|
|
|
aggressive |
5 |
|
|
|
|
|
|
|
|
|
|
natural |
5 |
|
|
|
|
|
|
|
|
|
|
responsive |
5 |
|
|
|
|
|
|
|
|
|
|
absence |
5 |
|
|
|
|
|
|
|
|
|
|
considered |
5 |
|
|
|
|
|
|
|
|
|
|
mapping |
5 |
|
|
|
|
|
|
|
|
|
|
providing |
5 |
|
|
|
|
|
|
|
|
|
|
united |
5 |
|
|
|
|
|
|
|
|
|
|
cardiovascular |
5 |
|
|
|
|
|
|
|
|
|
|
provides |
5 |
|
|
|
|
|
|
|
|
|
|
droughts |
5 |
|
|
|
|
|
|
|
|
|
|
loss |
5 |
|
|
|
|
|
|
|
|
|
|
pain |
5 |
|
|
|
|
|
|
|
|
|
|
glucose |
5 |
|
|
|
|
|
|
|
|
|
|
enter |
5 |
|
|
|
|
|
|
|
|
|
|
warming |
5 |
|
|
|
|
|
|
|
|
|
|
together |
5 |
|
|
|
|
|
|
|
|
|
|
k |
5 |
|
|
|
|
|
|
|
|
|
|
reported |
5 |
|
|
|
|
|
|
|
|
|
|
mean |
5 |
|
|
|
|
|
|
|
|
|
|
oxidation |
5 |
|
|
|
|
|
|
|
|
|
|
detect |
5 |
|
|
|
|
|
|
|
|
|
|
naive |
5 |
|
|
|
|
|
|
|
|
|
|
mating |
5 |
|
|
|
|
|
|
|
|
|
|
therapies |
5 |
|
|
|
|
|
|
|
|
|
|
sink |
5 |
|
|
|
|
|
|
|
|
|
|
computational |
5 |
|
|
|
|
|
|
|
|
|
|
vast |
5 |
|
|
|
|
|
|
|
|
|
|
o |
5 |
|
|
|
|
|
|
|
|
|
|
certain |
5 |
|
|
|
|
|
|
|
|
|
|
theoretical |
5 |
|
|
|
|
|
|
|
|
|
|
viable |
5 |
|
|
|
|
|
|
|
|
|
|
metabolic |
5 |
|
|
|
|
|
|
|
|
|
|
still |
5 |
|
|
|
|
|
|
|
|
|
|
design |
5 |
|
|
|
|
|
|
|
|
|
|
understood |
5 |
|
|
|
|
|
|
|
|
|
|
investigation |
5 |
|
|
|
|
|
|
|
|
|
|
neuronal |
5 |
|
|
|
|
|
|
|
|
|
|
lateral |
5 |
|
|
|
|
|
|
|
|
|
|
observed |
5 |
|
|
|
|
|
|
|
|
|
|
center |
5 |
|
|
|
|
|
|
|
|
|
|
clusters |
5 |
|
|
|
|
|
|
|
|
|
|
value |
5 |
|
|
|
|
|
|
|
|
|
|
signal |
5 |
|
|
|
|
|
|
|
|
|
|
cases |
5 |
|
|
|
|
|
|
|
|
|
|
land |
5 |
|
|
|
|
|
|
|
|
|
|
spread |
5 |
|
|
|
|
|
|
|
|
|
|
circuit |
5 |
|
|
|
|
|
|
|
|
|
|
necessary |
5 |
|
|
|
|
|
|
|
|
|
|
undergoes |
5 |
|
|
|
|
|
|
|
|
|
|
countries |
5 |
|
|
|
|
|
|
|
|
|
|
pre |
5 |
|
|
|
|
|
|
|
|
|
|
clearer |
5 |
|
|
|
|
|
|
|
|
|
|
acting |
5 |
|
|
|
|
|
|
|
|
|
|
identification |
5 |
|
|
|
|
|
|
|
|
|
|
linked |
5 |
|
|
|
|
|
|
|
|
|
|
experimental |
5 |
|
|
|
|
|
|
|
|
|
|
baseline |
5 |
|
|
|
|
|
|
|
|
|
|
antibiotics |
5 |
|
|
|
|
|
|
|
|
|
|
next |
5 |
|
|
|
|
|
|
|
|
|
|
females |
5 |
|
|
|
|
|
|
|
|
|
|
ii |
5 |
|
|
|
|
|
|
|
|
|
|
centers |
5 |
|
|
|
|
|
|
|
|
|
|
completely |
5 |
|
|
|
|
|
|
|
|
|
|
resource |
5 |
|
|
|
|
|
|
|
|
|
|
conduction |
5 |
|
|
|
|
|
|
|
|
|
|
atrial |
5 |
|
|
|
|
|
|
|
|
|
|
formed |
5 |
|
|
|
|
|
|
|
|
|
|
tests |
5 |
|
|
|
|
|
|
|
|
|
|
pmca1 |
5 |
|
|
|
|
|
|
|
|
|
|
accepted |
5 |
|
|
|
|
|
|
|
|
|
|
sequence |
5 |
|
|
|
|
|
|
|
|
|
|
mate |
5 |
|
|
|
|
|
|
|
|
|
|
integrin |
4 |
|
|
|
|
|
|
|
|
|
|
finding |
4 |
|
|
|
|
|
|
|
|
|
|
folding |
4 |
|
|
|
|
|
|
|
|
|
|
substrate |
4 |
|
|
|
|
|
|
|
|
|
|
topic |
4 |
|
|
|
|
|
|
|
|
|
|
interest |
4 |
|
|
|
|
|
|
|
|
|
|
continued |
4 |
|
|
|
|
|
|
|
|
|
|
record |
4 |
|
|
|
|
|
|
|
|
|
|
combining |
4 |
|
|
|
|
|
|
|
|
|
|
resting |
4 |
|
|
|
|
|
|
|
|
|
|
mainly |
4 |
|
|
|
|
|
|
|
|
|
|
recombination |
4 |
|
|
|
|
|
|
|
|
|
|
ultimately |
4 |
|
|
|
|
|
|
|
|
|
|
regeneration |
4 |
|
|
|
|
|
|
|
|
|
|
methodology |
4 |
|
|
|
|
|
|
|
|
|
|
characterize |
4 |
|
|
|
|
|
|
|
|
|
|
uncoupled |
4 |
|
|
|
|
|
|
|
|
|
|
concentration |
4 |
|
|
|
|
|
|
|
|
|
|
defects |
4 |
|
|
|
|
|
|
|
|
|
|
tolerance |
4 |
|
|
|
|
|
|
|
|
|
|
observations |
4 |
|
|
|
|
|
|
|
|
|
|
intervention |
4 |
|
|
|
|
|
|
|
|
|
|
patterns |
4 |
|
|
|
|
|
|
|
|
|
|
pathogenesis |
4 |
|
|
|
|
|
|
|
|
|
|
physiological |
4 |
|
|
|
|
|
|
|
|
|
|
subject |
4 |
|
|
|
|
|
|
|
|
|
|
instead |
4 |
|
|
|
|
|
|
|
|
|
|
relationship |
4 |
|
|
|
|
|
|
|
|
|
|
congenital |
4 |
|
|
|
|
|
|
|
|
|
|
vector |
4 |
|
|
|
|
|
|
|
|
|
|
main |
4 |
|
|
|
|
|
|
|
|
|
|
input |
4 |
|
|
|
|
|
|
|
|
|
|
developed |
4 |
|
|
|
|
|
|
|
|
|
|
similarity |
4 |
|
|
|
|
|
|
|
|
|
|
relatively |
4 |
|
|
|
|
|
|
|
|
|
|
zebrafish |
4 |
|
|
|
|
|
|
|
|
|
|
determined |
4 |
|
|
|
|
|
|
|
|
|
|
characteristic |
4 |
|
|
|
|
|
|
|
|
|
|
circadian |
4 |
|
|
|
|
|
|
|
|
|
|
phases |
4 |
|
|
|
|
|
|
|
|
|
|
onset |
4 |
|
|
|
|
|
|
|
|
|
|
unstable |
4 |
|
|
|
|
|
|
|
|
|
|
work |
4 |
|
|
|
|
|
|
|
|
|
|
fields |
4 |
|
|
|
|
|
|
|
|
|
|
correlated |
4 |
|
|
|
|
|
|
|
|
|
|
morbidity |
4 |
|
|
|
|
|
|
|
|
|
|
systemic |
4 |
|
|
|
|
|
|
|
|
|
|
diabetes |
4 |
|
|
|
|
|
|
|
|
|
|
polymer |
4 |
|
|
|
|
|
|
|
|
|
|
solid |
4 |
|
|
|
|
|
|
|
|
|
|
generally |
4 |
|
|
|
|
|
|
|
|
|
|
help |
4 |
|
|
|
|
|
|
|
|
|
|
alternans |
4 |
|
|
|
|
|
|
|
|
|
|
proportion |
4 |
|
|
|
|
|
|
|
|
|
|
initiated |
4 |
|
|
|
|
|
|
|
|
|
|
four |
4 |
|
|
|
|
|
|
|
|
|
|
historical |
4 |
|
|
|
|
|
|
|
|
|
|
developments |
4 |
|
|
|
|
|
|
|
|
|
|
antibiotic |
4 |
|
|
|
|
|
|
|
|
|
|
bacteria |
4 |
|
|
|
|
|
|
|
|
|
|
alleles |
4 |
|
|
|
|
|
|
|
|
|
|
regulatory |
4 |
|
|
|
|
|
|
|
|
|
|
called |
4 |
|
|
|
|
|
|
|
|
|
|
maintenance |
4 |
|
|
|
|
|
|
|
|
|
|
monitoring |
4 |
|
|
|
|
|
|
|
|
|
|
hours |
4 |
|
|
|
|
|
|
|
|
|
|
biased |
4 |
|
|
|
|
|
|
|
|
|
|
given |
4 |
|
|
|
|
|
|
|
|
|
|
metal |
4 |
|
|
|
|
|
|
|
|
|
|
rich |
4 |
|
|
|
|
|
|
|
|
|
|
layer |
4 |
|
|
|
|
|
|
|
|
|
|
beyond |
4 |
|
|
|
|
|
|
|
|
|
|
task |
4 |
|
|
|
|
|
|
|
|
|
|
marine |
4 |
|
|
|
|
|
|
|
|
|
|
15 |
4 |
|
|
|
|
|
|
|
|
|
|
50 |
4 |
|
|
|
|
|
|
|
|
|
|
near |
4 |
|
|
|
|
|
|
|
|
|
|
third |
4 |
|
|
|
|
|
|
|
|
|
|
training |
4 |
|
|
|
|
|
|
|
|
|
|
skills |
4 |
|
|
|
|
|
|
|
|
|
|
plasticity |
4 |
|
|
|
|
|
|
|
|
|
|
characterized |
4 |
|
|
|
|
|
|
|
|
|
|
wall |
4 |
|
|
|
|
|
|
|
|
|
|
pathogen |
4 |
|
|
|
|
|
|
|
|
|
|
antigen |
4 |
|
|
|
|
|
|
|
|
|
|
biomarkers |
4 |
|
|
|
|
|
|
|
|
|
|
lc |
4 |
|
|
|
|
|
|
|
|
|
|
allows |
4 |
|
|
|
|
|
|
|
|
|
|
strongly |
4 |
|
|
|
|
|
|
|
|
|
|
y |
4 |
|
|
|
|
|
|
|
|
|
|
electrical |
4 |
|
|
|
|
|
|
|
|
|
|
place |
4 |
|
|
|
|
|
|
|
|
|
|
droplet |
4 |
|
|
|
|
|
|
|
|
|
|
acquired |
4 |
|
|
|
|
|
|
|
|
|
|
appropriate |
4 |
|
|
|
|
|
|
|
|
|
|
burden |
4 |
|
|
|
|
|
|
|
|
|
|
precise |
4 |
|
|
|
|
|
|
|
|
|
|
give |
4 |
|
|
|
|
|
|
|
|
|
|
allowing |
4 |
|
|
|
|
|
|
|
|
|
|
behavioral |
4 |
|
|
|
|
|
|
|
|
|
|
selectivity |
4 |
|
|
|
|
|
|
|
|
|
|
stimuli |
4 |
|
|
|
|
|
|
|
|
|
|
down |
4 |
|
|
|
|
|
|
|
|
|
|
various |
4 |
|
|
|
|
|
|
|
|
|
|
moreover |
4 |
|
|
|
|
|
|
|
|
|
|
generated |
4 |
|
|
|
|
|
|
|
|
|
|
examined |
4 |
|
|
|
|
|
|
|
|
|
|
co |
4 |
|
|
|
|
|
|
|
|
|
|
repeated |
4 |
|
|
|
|
|
|
|
|
|
|
visits |
4 |
|
|
|
|
|
|
|
|
|
|
77 |
4 |
|
|
|
|
|
|
|
|
|
|
became |
4 |
|
|
|
|
|
|
|
|
|
|
domains |
4 |
|
|
|
|
|
|
|
|
|
|
combined |
4 |
|
|
|
|
|
|
|
|
|
|
nmr |
4 |
|
|
|
|
|
|
|
|
|
|
strains |
4 |
|
|
|
|
|
|
|
|
|
|
newly |
4 |
|
|
|
|
|
|
|
|
|
|
comparing |
4 |
|
|
|
|
|
|
|
|
|
|
drosophila |
4 |
|
|
|
|
|
|
|
|
|
|
alpha |
4 |
|
|
|
|
|
|
|
|
|
|
coming |
4 |
|
|
|
|
|
|
|
|
|
|
efficiency |
4 |
|
|
|
|
|
|
|
|
|
|
composition |
4 |
|
|
|
|
|
|
|
|
|
|
eventually |
4 |
|
|
|
|
|
|
|
|
|
|
precision |
4 |
|
|
|
|
|
|
|
|
|
|
therapeutics |
4 |
|
|
|
|
|
|
|
|
|
|
polymerization |
4 |
|
|
|
|
|
|
|
|
|
|
pathway |
4 |
|
|
|
|
|
|
|
|
|
|
functionally |
4 |
|
|
|
|
|
|
|
|
|
|
images |
4 |
|
|
|
|
|
|
|
|
|
|
12 |
4 |
|
|
|
|
|
|
|
|
|
|
yield |
4 |
|
|
|
|
|
|
|
|
|
|
nerve |
4 |
|
|
|
|
|
|
|
|
|
|
profiles |
4 |
|
|
|
|
|
|
|
|
|
|
repeats |
4 |
|
|
|
|
|
|
|
|
|
|
success |
4 |
|
|
|
|
|
|
|
|
|
|
spring |
4 |
|
|
|
|
|
|
|
|
|
|
earlier |
4 |
|
|
|
|
|
|
|
|
|
|
22 |
4 |
|
|
|
|
|
|
|
|
|
|
translation |
4 |
|
|
|
|
|
|
|
|
|
|
towards |
4 |
|
|
|
|
|
|
|
|
|
|
full |
4 |
|
|
|
|
|
|
|
|
|
|
itself |
4 |
|
|
|
|
|
|
|
|
|
|
persistent |
4 |
|
|
|
|
|
|
|
|
|
|
deep |
4 |
|
|
|
|
|
|
|
|
|
|
retrospective |
4 |
|
|
|
|
|
|
|
|
|
|
depressive |
4 |
|
|
|
|
|
|
|
|
|
|
simple |
4 |
|
|
|
|
|
|
|
|
|
|
ubiquitous |
4 |
|
|
|
|
|
|
|
|
|
|
intracellular |
4 |
|
|
|
|
|
|
|
|
|
|
incorporated |
4 |
|
|
|
|
|
|
|
|
|
|
cytokines |
4 |
|
|
|
|
|
|
|
|
|
|
embryonic |
4 |
|
|
|
|
|
|
|
|
|
|
practice |
4 |
|
|
|
|
|
|
|
|
|
|
children |
4 |
|
|
|
|
|
|
|
|
|
|
protect |
4 |
|
|
|
|
|
|
|
|
|
|
ige |
4 |
|
|
|
|
|
|
|
|
|
|
effector |
4 |
|
|
|
|
|
|
|
|
|
|
broad |
4 |
|
|
|
|
|
|
|
|
|
|
scientists |
4 |
|
|
|
|
|
|
|
|
|
|
drought |
4 |
|
|
|
|
|
|
|
|
|
|
artery |
4 |
|
|
|
|
|
|
|
|
|
|
serious |
4 |
|
|
|
|
|
|
|
|
|
|
cannabis |
4 |
|
|
|
|
|
|
|
|
|
|
donors |
4 |
|
|
|
|
|
|
|
|
|
|
nanoscale |
4 |
|
|
|
|
|
|
|
|
|
|
th |
4 |
|
|
|
|
|
|
|
|
|
|
muscle |
4 |
|
|
|
|
|
|
|
|
|
|
limit |
4 |
|
|
|
|
|
|
|
|
|
|
altered |
4 |
|
|
|
|
|
|
|
|
|
|
rarely |
4 |
|
|
|
|
|
|
|
|
|
|
post |
4 |
|
|
|
|
|
|
|
|
|
|
transitions |
4 |
|
|
|
|
|
|
|
|
|
|
ends |
4 |
|
|
|
|
|
|
|
|
|
|
degradation |
4 |
|
|
|
|
|
|
|
|
|
|
obesity |
4 |
|
|
|
|
|
|
|
|
|
|
late |
4 |
|
|
|
|
|
|
|
|
|
|
agonist |
4 |
|
|
|
|
|
|
|
|
|
|
application |
4 |
|
|
|
|
|
|
|
|
|
|
refractory |
4 |
|
|
|
|
|
|
|
|
|
|
r |
4 |
|
|
|
|
|
|
|
|
|
|
native |
4 |
|
|
|
|
|
|
|
|
|
|
accordingly |
4 |
|
|
|
|
|
|
|
|
|
|
proposed |
4 |
|
|
|
|
|
|
|
|
|
|
massive |
4 |
|
|
|
|
|
|
|
|
|
|
crop |
4 |
|
|
|
|
|
|
|
|
|
|
power |
4 |
|
|
|
|
|
|
|
|
|
|
visible |
4 |
|
|
|
|
|
|
|
|
|
|
advent |
4 |
|
|
|
|
|
|
|
|
|
|
regulators |
4 |
|
|
|
|
|
|
|
|
|
|
ag |
4 |
|
|
|
|
|
|
|
|
|
|
better |
4 |
|
|
|
|
|
|
|
|
|
|
affected |
4 |
|
|
|
|
|
|
|
|
|
|
cleared |
4 |
|
|
|
|
|
|
|
|
|
|
until |
4 |
|
|
|
|
|
|
|
|
|
|
occurred |
4 |
|
|
|
|
|
|
|
|
|
|
inactive |
4 |
|
|
|
|
|
|
|
|
|
|
indicated |
4 |
|
|
|
|
|
|
|
|
|
|
influenza |
4 |
|
|
|
|
|
|
|
|
|
|
developing |
4 |
|
|
|
|
|
|
|
|
|
|
transfer |
4 |
|
|
|
|
|
|
|
|
|
|
enzyme |
4 |
|
|
|
|
|
|
|
|
|
|
cognitive |
4 |
|
|
|
|
|
|
|
|
|
|
zika |
4 |
|
|
|
|
|
|
|
|
|
|
flux |
4 |
|
|
|
|
|
|
|
|
|
|
h2 |
4 |
|
|
|
|
|
|
|
|
|
|
dominated |
4 |
|
|
|
|
|
|
|
|
|
|
what |
4 |
|
|
|
|
|
|
|
|
|
|
broadly |
4 |
|
|
|
|
|
|
|
|
|
|
efficient |
4 |
|
|
|
|
|
|
|
|
|
|
inflammation |
4 |
|
|
|
|
|
|
|
|
|
|
allergy |
4 |
|
|
|
|
|
|
|
|
|
|
residues |
4 |
|
|
|
|
|
|
|
|
|
|
follow |
4 |
|
|
|
|
|
|
|
|
|
|
principles |
4 |
|
|
|
|
|
|
|
|
|
|
vision |
4 |
|
|
|
|
|
|
|
|
|
|
prevent |
4 |
|
|
|
|
|
|
|
|
|
|
exposed |
4 |
|
|
|
|
|
|
|
|
|
|
opposite |
4 |
|
|
|
|
|
|
|
|
|
|
basis |
4 |
|
|
|
|
|
|
|
|
|
|
limiting |
4 |
|
|
|
|
|
|
|
|
|
|
ratios |
4 |
|
|
|
|
|
|
|
|
|
|
below |
4 |
|
|
|
|
|
|
|
|
|
|
substantial |
4 |
|
|
|
|
|
|
|
|
|
|
adverse |
4 |
|
|
|
|
|
|
|
|
|
|
test |
4 |
|
|
|
|
|
|
|
|
|
|
researchers |
4 |
|
|
|
|
|
|
|
|
|
|
repair |
4 |
|
|
|
|
|
|
|
|
|
|
bioinformatics |
4 |
|
|
|
|
|
|
|
|
|
|
re |
4 |
|
|
|
|
|
|
|
|
|
|
decision |
4 |
|
|
|
|
|
|
|
|
|
|
public |
4 |
|
|
|
|
|
|
|
|
|
|
event |
4 |
|
|
|
|
|
|
|
|
|
|
oxidized |
4 |
|
|
|
|
|
|
|
|
|
|
modern |
4 |
|
|
|
|
|
|
|
|
|
|
fatty |
4 |
|
|
|
|
|
|
|
|
|
|
25 |
4 |
|
|
|
|
|
|
|
|
|
|
commercial |
4 |
|
|
|
|
|
|
|
|
|
|
exist |
4 |
|
|
|
|
|
|
|
|
|
|
unknown |
4 |
|
|
|
|
|
|
|
|
|
|
phenotypes |
4 |
|
|
|
|
|
|
|
|
|
|
advanced |
4 |
|
|
|
|
|
|
|
|
|
|
damaged |
4 |
|
|
|
|
|
|
|
|
|
|
resident |
4 |
|
|
|
|
|
|
|
|
|
|
supporting |
4 |
|
|
|
|
|
|
|
|
|
|
stroke |
4 |
|
|
|
|
|
|
|
|
|
|
mechanical |
4 |
|
|
|
|
|
|
|
|
|
|
ablation |
4 |
|
|
|
|
|
|
|
|
|
|
made |
4 |
|
|
|
|
|
|
|
|
|
|
added |
4 |
|
|
|
|
|
|
|
|
|
|
median |
4 |
|
|
|
|
|
|
|
|
|
|
testing |
4 |
|
|
|
|
|
|
|
|
|
|
zygotic |
4 |
|
|
|
|
|
|
|
|
|
|
loci |
4 |
|
|
|
|
|
|
|
|
|
|
crispr |
4 |
|
|
|
|
|
|
|
|
|
|
nucleus |
4 |
|
|
|
|
|
|
|
|
|
|
disability |
4 |
|
|
|
|
|
|
|
|
|
|
mitoneet |
4 |
|
|
|
|
|
|
|
|
|
|
engram |
4 |
|
|
|
|
|
|
|
|
|
|
pancreatic |
4 |
|
|
|
|
|
|
|
|
|
|
developmental |
4 |
|
|
|
|
|
|
|
|
|
|
soon |
4 |
|
|
|
|
|
|
|
|
|
|
elections |
4 |
|
|
|
|
|
|
|
|
|
|
additional |
4 |
|
|
|
|
|
|
|
|
|
|
predominant |
4 |
|
|
|
|
|
|
|
|
|
|
aortic |
4 |
|
|
|
|
|
|
|
|
|
|
organism |
4 |
|
|
|
|
|
|
|
|
|
|
lithium |
4 |
|
|
|
|
|
|
|
|
|
|
pups |
4 |
|
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。